Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
EspaƱol
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
A Randomized Trial Of Low-Dose Bevacizumab Versus Laser For Type 1 Retinopathy Of Prematurity
Franklin, John
(PI)
Opthalmology
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Nursing and Health Professions
Low Drug Dose
100%
Bevacizumab
100%
Retrolental Fibroplasia
100%
Retinopathy
100%
Visual Acuity
66%
Visual Field
66%
Refraction Error
66%
Laser Coagulation
33%
Morbidity
33%
Retreatment
33%
Clinical Trial
33%
Pharmacology, Toxicology and Pharmaceutical Science
Bevacizumab
100%
Retrolental Fibroplasia
100%
Retinopathy
100%
Refraction Error
66%
Randomized Clinical Trial
33%
Morbidity
33%